Gene: NUDCD2
Official Full Name: NudC domain containing 2provided by HGNC
Gene Summary: Predicted to enable unfolded protein binding activity. Predicted to be involved in protein folding. Located in cytosol; intercellular bridge; and mitotic spindle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26438 | NUDCD2 Knockout cell line (HeLa) | Human | NUDCD2 | 1:3~1:6 | Negative | Online Inquiry |
KO26439 | NUDCD2 Knockout cell line (HCT 116) | Human | NUDCD2 | 1:2~1:4 | Negative | Online Inquiry |
KO26440 | NUDCD2 Knockout cell line (HEK293) | Human | NUDCD2 | 1:3~1:6 | Negative | Online Inquiry |
KO26441 | NUDCD2 Knockout cell line (A549) | Human | NUDCD2 | 1:3~1:4 | Negative | Online Inquiry |
NUDCD2 Gene Knockout Cell Lines are genetically engineered cell lines designed to specifically disrupt the function of the NUDCD2 gene, a critical regulator in cellular processes, including mitosis and the DNA damage response. These knockout cell lines provide a robust model for studying the functional implications of NUDCD2 gene loss, enabling researchers to investigate its role in various biological contexts and disease states.
The key mechanism by which these knockout cell lines operate is through the targeted deletion of the NUDCD2 gene, achieved via CRISPR/Cas9 technology or other gene editing techniques. This results in a lack of functional NUDCD2 protein, thereby allowing scientists to elucidate the downstream effects of its absence on cell cycle regulation, genomic integrity, and cellular stress responses. By providing these specific models, researchers can gain insights into how disruptions in NUDCD2 contribute to diseases such as cancer, neurodegenerative disorders, and other pathologies.
The scientific importance of NUDCD2 Gene Knockout Cell Lines is particularly pronounced in both basic research and clinical applications. In oncological research, these cell lines facilitate the exploration of tumorigenic pathways and the development of targeted therapies. In clinical settings, understanding the role of NUDCD2 can guide potential therapeutic strategies for patients with aberrant function or expression of this gene.
Unique selling points of our NUDCD2 Gene Knockout Cell Lines include their high specificity and reproducibility, combined with extensive characterizations that validate their functionality. Compared to traditional models, these cell lines save time and resources by providing a ready-to-use platform for investigators who wish to focus on functional assessments rather than enduring extensive engineering processes.
Researchers and clinicians will find immense value in this product as it unpacks complex biological mechanisms, fosters innovation, and accelerates translational research. The capability to create and manipulate such models places our customers at the forefront of scientific discovery. Our company, backed by a team of experts in genetic engineering and molecular biology, remains dedicated to delivering high-quality biological tools that propel research forward and contribute to advancements in human health.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.